Discover 1,164 paid clinical trials in Cincinnati, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
With a focus on a variety of conditions such as lymphoma, cancer, neurological diseases, and sleep apnea, Cincinnati is home to a wide array of clinical studies. The city's leading medical centers are actively recruiting participants, offering paid research opportunities for healthy volunteers or trials for specific health conditions, providing access to innovative treatments and therapies.
Filter
2
Filter results
Results: 1,164
Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System
Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy
for
Malignant Solid Neoplasm
Location: Cincinnati OH, Lexington KY, Johnson City TN,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05642611
Phase3, Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
for
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma,
Location: Cincinnati OH, Lexington KY, Mount Sterling KY,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT04566328
Phase3, Recruiting
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
for
Biochemically Recurrent Prostate Carcinoma,
Location: Cincinnati OH, Lexington KY, Columbus OH, Danville IL,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: Male
Age: 18+
Code: NCT04423211
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
for
Triple Negative Breast Cancer
Location: Cincinnati OH, Louisville KY, Indianapolis IN,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT05633654
Phase3, Recruiting
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
for
Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8,
Location: Cincinnati OH, Lexington KY, Mount Sterling KY,
Sponsor: SWOG Cancer Research Network
Sex: Male
Age: 18+
Code: NCT05806515
Phase2, Recruiting
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
for
Multiple Myeloma
Location: Cincinnati OH, Indianapolis IN, Cleveland OH,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT06152575
Phase3, Recruiting
Impact of Integrated Care Pathways for Prevention of Post-operative Urinary Retention (POUR)